secwatch / observer

KB HOME — fact timeline

Source-grounded facts extracted from KB HOME's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

KBH KB HOME JSON

Robert R. Dillard resigned as Executive Vice President and Chief Financial Officer at KB HOME.

“On April 29, 2026, Robert R. Dillard, KB Home ’ s Executive Vice President and Chief Financial Officer, resigned from his position, effective May 8, 2026.”
Debt Financings

KB HOME incurred revolving credit of up to $1.2 billion with Bank of America, N.A., as administrative agent at term SOFR, daily SOFR or base rate, plus a spread ranging from 1.25% to 1.75% fo maturing November 12, 2030.

“On November 12, 2025, KB Home (the “Company”) entered into a revolving credit agreement (“Revolving Facility”) with the lenders party thereto and Bank of America, N.A., as administrative agent, providing the aggregate commitment of the lenders to make revolving loans to the Company in an amount of up to $1.2 billion.”

Robert R. Dillard was appointed as Executive Vice President and Chief Financial Officer at KB HOME.

“On March 24, 2025, KB Home announced the appointment, effective March 31, 2025, of Robert R. Dillard as its Executive Vice President and Chief Financial Officer.”

Cheryl J. Henry was elected as Director at KB HOME.

“On October 10, 2024, the KB Home board of directors elected Ms. Cheryl J. Henry as a director for a term ending at KB Home’s 2025 Annual Meeting of Stockholders and appointed her to the board’s nominating and corporate governance committee.”

Jeff J. Kaminski departed as Executive Vice President and Chief Financial Officer at KB HOME.

“On September 25, 2024, Jeff J. Kaminski notified KB Home of his intention to retire as Executive Vice President and Chief Financial Officer in early 2025, after more than 14 years of service.”
Governance Changes

KB HOME: Amended and Restated By-Laws revising Section 2.10 to narrow the range of information required regarding certain related parties when providing advance notice of stockholder-nominated director candidates, and revising Section 3.14 to clarify that Director Emeritus appointments are subject to the con (effective 2024-04-18).

“On April 18, 2024, the board of directors approved Amended and Restated By-Laws of KB Home, effective immediately, revising provisions in Section 2.10 to narrow the range of information required as to certain related parties and certain other persons in connection with providing advance notice of stockholder-nominated director candidates, and in Section 3.14 to clarify, consistent with a legal ruling invalidating prior language that did not expressly state, that Director Emeritus appointments are subject to the consent of the director being appointed.”
Shareholder Votes

KB HOME shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2024-04-18 meeting.

“3. The vote to ratify Ernst & Young LLP’s appointment as KB Home’s independent registered public accounting firm for the fiscal year ending November 30, 2024 was as follows: For % Against % Abstentions Broker Non-Votes 73,628,333 97.2% 2,069,848 2.7% 29,448 N/A”
Shareholder Votes

KB HOME shareholders approved Non-binding advisory vote to approve named executive officer compensation at the 2024-04-18 meeting.

“2. The non-binding advisory vote to approve named executive officer compensation was as follows: For % Against % Abstentions Broker Non-Votes 57,840,577 81.0% 13,148,062 18.4% 454,316 4,284,674”
Shareholder Votes

KB HOME shareholders approved Election of Directors at the 2024-04-18 meeting.

“1. The vote on the nominees for election to the KB Home board of directors was as follows: Director For % Against % Abstentions Broker Non-Votes Jose M. Barra 71,152,875 99.6% 261,417 0.4% 28,663 4,284,674 Arthur R. Collins 67,796,739 94.9% 3,616,773 5.1% 29,443 4,284,674 Dorene C. Dominguez 69,003,990 96.6% 2,410,215 3.4% 28,750 4,284,674 Kevin P. Eltife 68,679,304 96.2% 2,730,849 3.8% 32,802 4,284,674 Dr. Stuart A. Gabriel 71,147,047 99.6% 268,939 0.4% 26,969 4,284,674 Dr. Thomas W. Gilligan 68,019,454 95.2% 3,395,280 4.8% 28,221 4,284,674 Jodeen A. Kozlak 69,652,428 97.5% 1,758,855 2.5% 31,672 4,284,674 Jeffrey T. Mezger 68,616,024 96.5% 2,519,216 3.5% 307,715 4,284,674 James C. Weaver 59,053,860 82.7% 12,360,999 17.3% 28,096 4,284,674”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.